PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: Two PTX abstracts accepted at prestigious ISCT conference, page-12

  1. 216 Posts.
    lightbulb Created with Sketch. 27
    I am a long-term holder and still quite bullish on PTX but I think there is some overhyping this conference abstract thing. I have presented at medical conference and submitted abstracts to "prestigious" journals in a previous life. It's really not a big deal. Some senior researcher says to a junior - "Rustle up an abstract about something you are doing" and lets submit it to this conference. There is really minimal peer review of the 100's or 1000's of abstracts submitted and most all are published in a conference edition of some or other journal, even well-regarded. I have previously had to search long and hard to even find my abstract in the journal. I think the non-executive appointment sounds better news.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.